EVIDENCE FOR COMMON SIGNALING PATHWAYS OF GNRH RECEPTOR AND FAS IN TUMORS

Citation
T. Fuseya et al., EVIDENCE FOR COMMON SIGNALING PATHWAYS OF GNRH RECEPTOR AND FAS IN TUMORS, Oncology Reports, 3(6), 1996, pp. 1111-1113
Citations number
22
Categorie Soggetti
Oncology
Journal title
ISSN journal
1021335X
Volume
3
Issue
6
Year of publication
1996
Pages
1111 - 1113
Database
ISI
SICI code
1021-335X(1996)3:6<1111:EFCSPO>2.0.ZU;2-N
Abstract
Fas, a cell surface receptor, mediates cell death by means of apoptosi s in a variety of cell types. GnRH receptor-bearing tumors undergo apo ptosis with GnRH analogs. To examine whether Fas and GnRH receptor sha re the same signal transduction pathway, we attempted to detect Fas-li nked responses within plasma membrane isolated from GnRH receptor-bear ing tumors. Surgically removed gynecological tumors were screened for Fas and GnRH receptor expression prior to analyses. The plasma membran es from these tumors responded to anti-Fas antibody (N-18) exposure wi th an inhibition in phosphatidylinositol (PtdIns) kinase activity, ana logous to response to GnRH analog (buserelin) exposure; the activity w as measured as phosphorylation from [gamma-P-32]ATP of exogenous subst rate PtdIns by the purified plasma membranes. This inhibition was depe ndent on the N-18 dose, and a maximal effect occurred at 300 ng/ml wit h 60% decrease in PtdIns phosphorylation. The maximal inhibitory effec ts of N-18 and buserelin were not additive on PtdIns kinase inhibition ; inhibition by both N-18 and GnRH analog was no greater than with eit her one alone. These data might suggest that there may be at least som e similarity in signal transduction pathway utilized by GnRH analogs a nd Fas ligands.